News

ALR Technologies Announces Second Generation GluCurve Pet CGM for Diabetic Cats and Dogs

SINGAPORE, June 01, 2023 (GLOBE NEWSWIRE) -- ALR Technologies SG Ltd. (“ALRT”) (OTCQB:ALRTF), the diabetes management company, announces the issuance…

1 year ago

The International Myeloma Foundation (IMF) Honors 2023 Research Achievement Awardees, Dr. Maria-Victoria Mateos and Dr. Thomas Martin

LOS ANGELES, June 01, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is proud to announce the recipients of…

1 year ago

Palisade Bio Promotes J.D. Finley to Chief Executive Officer

Carlsbad, CA, June 01, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company advancing therapies…

1 year ago

Aleafia Health Announces Extension of Forbearance Under Loan Agreement With Senior Lender

TORONTO, June 01, 2023 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) announces…

1 year ago

Mark Cuban Cost Plus Drug Company joins forces with Coherus to make YUSIMRY™, a HUMIRA® biosimilar, available to patients

–  YUSIMRY™ (adalimumab-aqvh) will be the first biologic product offered by the Mark Cuban Cost Plus Drug Company  – –  YUSIMRY will…

1 year ago

Culture Biosciences Establishes Advisory Board of Biotech and Biopharma Executives to Guide the Corporate Strategy and Accelerate Growth

Seasoned sector leaders will advise Culture’s leadership in customer intelligence and innovationSAN FRANCISCO, June 01, 2023 (GLOBE NEWSWIRE) -- Culture…

1 year ago

Ambrx to Present at Multiple Upcoming Investor Meetings

SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (or the “Company”) (NASDAQ: AMAM), today announced…

1 year ago

Dr. Diego Diaz Collaborates with Castle Connolly Private Health Partners to Create a Concierge Medical Program that Offers a Personalized Approach to Patient Care

D. Diaz CCPHP Dr. Diego Diaz Collaborates with Castle Connolly Private Health Partners to Create a Concierge Medical Program that…

1 year ago

Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference

SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its…

1 year ago

T2 Biosystems Announces Second Largest Sepsis-Driven Instrument Sale in Company History

LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens…

1 year ago